characteristics.text: SAMN17083557
characteristics.characteristic: External Id
characteristics.text: Department of Immunology, Medical University of Warsaw
characteristics.characteristic: INSDC center name
characteristics.text: 2022-01-20T00:00:00Z
characteristics.characteristic: INSDC first public
characteristics.text: 2022-01-20T01:26:16.643Z
characteristics.characteristic: INSDC last update
characteristics.text: SRS7884101
characteristics.characteristic: INSDC secondary accession
characteristics.text: live
characteristics.characteristic: INSDC status
characteristics.text: Generic
characteristics.characteristic: NCBI submission model
characteristics.text: Generic.1.0
characteristics.characteristic: NCBI submission package
characteristics.text: SRS7884101
characteristics.characteristic: SRA accession
characteristics.text: lymphoblasts (CD19+) - patient derived xenograft cells
characteristics.characteristic: cell type
characteristics.text: Homo sapiens
characteristics.ontologyTerms: http://purl.obolibrary.org/obo/NCBITaxon_9606
characteristics.characteristic: organism
characteristics.text: MLL-AF4+ acute lymphoblastic leukemia, patient derived xenograft
characteristics.characteristic: source_name
characteristics.text: spleen
characteristics.ontologyTerms: http://purl.obolibrary.org/obo/BTO_0001281
characteristics.characteristic: tissue
characteristics.text: RNA-seq in MLL-AF4 patient derived xenograft cells - VEN_2
characteristics.characteristic: title
characteristics.text: 100 mg/kg of venetoclax (oral gavage) for 3 weeks
characteristics.characteristic: treatment